Indivior announces completion of redomiciliation to U.S.

Indivior (INDV) Pharmaceuticals announced completion of its redomiciliation from the United Kingdom to the United States. As a result, Indivior Pharmaceuticals, a new Delaware corporation, has become the new parent company. Indivior PLC is renamed Indivior and has become a wholly-owned subsidiary of IPI. The common stock of Indivior Pharmaceuticals is listed on Nasdaq and will continue to trade under the symbol “INDV.”